Join our daily newsletter At The Bell to receive exclusive market insights
- Hearing technology company Nuheara (NUH) places its shares in a trading halt pending the release of a capital raising announcement
- The company will remain in the halt until the earlier of Monday, September 5, or when the announcement is released to the public
- Prior to entering the halt, Nuheara revealed its hearing aids would be sold directly to customers in the US without a medical exam
- Following a 60-day enactment period, sales are expected to begin in mid-October
- Shares in Nuheara last traded at 24 cents on August 31
Hearing technology company Nuheara (NUH) has placed its shares in a trading halt pending the release of a capital raising announcement.
The company will remain in the halt until the earlier of Monday, September 5, or when the announcement is released to the public.
Nuheara is yet to disclose how much it intends to raise or what it will use the funds for once received.
Prior to entering the halt, Nuheara revealed its hearing aids would be sold directly to customers in the United States without a medical exam.
In a world first, the US Food and Drug Administration made a landmark decision and established a regulatory category for over-the-counter (OTC) hearing aids in the US.
This ruling allows hearing aids in the OTC category to be sold directly to customers in-store and online without a medical exam or audiologist fitting.
Following a 60-day enactment period, sales are expected to begin in mid-October.
Shares in Nuheara last traded at 24 cents on August 31. The company has a $32.92 million market cap.
